Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China flag China · Delayed Price · Currency is CNY
38.75
-0.02 (-0.05%)
At close: Mar 6, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Medical Products
3.60B3.53B3.43B2.91B
Medical Products Growth
2.03%3.09%17.71%-
Total
3.60B3.53B3.43B2.91B
Total Growth
2.03%3.09%17.71%-

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Mainland China
3.40B3.40B3.36B-
Mainland China Growth
-0.03%1.22%--
Other Countries and Regions
202.96M129.94M64.97M48.73M
Other Countries and Regions Growth
56.20%99.99%33.34%-
China
---2.73B
Total
3.60B3.53B3.43B2.78B
Total Growth
2.03%3.09%23.33%-
Source: S&P Global Market Intelligence.